Find the latest in EPAD news and research
-
|
Read more: EPAD at AD/PD2025The AD/PD™ Alzheimer’s disease and Parkinson’s disease Conference took place between 1-5 April in Vienna, Austria. The conference presented all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug…
All news and research
-
|
Members of the European Prevention of Alzheimer’s Dementia (EPAD) Work Package 6 (WP6) communication and dissemination team met on the Novartis…
-
|
What is your current role in EPAD? I work on ethical and social questions related to the development of the EPAD…
-
|
What is your current role in EPAD? With Carlos Díaz, we are co-leads of WP5 (Project Management) together with Janssen, being…
-
|
Another EPAD year has passed and we are proud to look back at a lot of successful deliveries and established relationships…
-
|
We are pleased to announce the arrival of a new project partner, Roche. We say a warm welcome to Roche and…
-
|
With the beginning of this new year, the EPAD project is celebrating it’s 2nd birthday. 2016 was truly exceptional, with the…
-
|
Our sister project, Amyloid imaging to prevent Alzheimer’s disease (AMYPAD), which began its activities on 1 October 2016, has recently been…
-
|
On 9 and 10 January, members of the work packages for the EPAD (European Prevention of Alzheimer’s Dementia) and AMYPAD (AMYloid…
-
|
On 13 December 2016, the Financial Times (FT) published a letter to the Editor, from EPAD Executive Committee member Dr Jose…
-
|
On 29 November, the Slovak Presidency of the European Union organised a conference on “Alzheimer’s disease – epidemic of the third…
-
|
Current Alzheimer’s disease (AD) research initiatives focus on cognitively healthy individuals with biomarkers that are associated with the development of AD.…
-
|
On 10 November 2016, the European Prevention of Alzheimer’s Dementia (EPAD) initiative held a public conference in Geneva, Switzerland, in collaboration…
-
Psychological, behavioral and social effects ofdisclosing Alzheimer’s disease biomarkers toresearch participants: a systematic review
-
|
What is your current role in EPAD? I am co-chair with Michael Ropacki of the Clinical and Cognitive Outcomes Scientific Advisory…
-
|
What is your current role in EPAD? I am the industry co-lead for Work Package 6, together with Jean Georges from…
-
|
We are thrilled to report on recent progress on the European Prevention of Alzheimer’s Dementia (EPAD) study – just as we…
-
|
Today, our new sister project Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) announces the launch of its novel research initiative, bringing…
-
Detecting cognitive changes in preclinical Alzheimer’s disease:A review of its feasibility
-
Recommended cognitive outcomes in preclinical Alzheimer’sdisease – Consensus statement from the European Preventionof Alzheimer’s Dementia
-
|
AMYPAD is a European project to establish the true value of amyloid PET in a diagnostic and prognostic setting (http://www.amypad.eu/). This…
-
|
What is your current role in EPAD? I am one of the leaders of Work package 2 as well as a…
No posts were found.
No posts were found.
No posts were found.